Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study

A correction to this paper has been published:https://doi.org/10.1007/s00431-021-04117-9
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research